• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Uruguay- 2016 Dengue

Shiloh

Editor, Senior Moderator
Source: http://www.who.int/csr/don/25-february-2016-dengue/en/
[h=1]Dengue Fever ? Uruguay[/h] Disease Outbreak News
25 February 2016

On 13 February 2016, the National IHR Focal Point (IHR NFP) of Uruguay notified PAHO/WHO a case of dengue.
The case is a 31-year-old female from Montevideo who developed fever and joint pain on 5 February. On 9 February, she sought medical attention and, on the same day, her samples were collected for laboratory testing. The samples tested positive for dengue by reverse transcription polymerase chain reaction. The patient remained hospitalized for two days and, at discharge, was in good health conditions. The patient has no history of travel outside of Uruguay.
Patient?s samples have been sent to a regional reference laboratory for confirmation. Results of entomological investigations are currently not available.
[h=3]Public health response[/h] Health authorities in Uruguay are conducting epidemiological investigations to determine the source of exposure and to identify possible additional cases in the community. Furthermore, they are strengthening vector control activities.
[h=3]WHO risk assessment[/h] If confirmed, this would be the first case of autochthonous dengue fever detected in Uruguay. Uruguay is one of the few countries in Central and South America that does not have the disease. The detection of one case would only demonstrate that an environment favourable to the proliferation of the Aedes Aegypti mosquitoes was present. In fact, Uruguay?s proximity to neighbouring Brazil and Argentina, where the disease is prevalent, inevitably puts the country at risk of contagion. The Aedes mosquitoes, the primary vector for transmission, can be carried into the country by personal vehicles and delivery trucks. Another factor that may facilitate the proliferation of these mosquitoes (and, in turn, the spread of the disease) in Uruguay is the extensive flooding of the Uruguay River.
[h=3]WHO advice[/h] The proximity of mosquito vector breeding sites to human habitation is a significant risk factor for dengue virus infection. Prevention and control relies on reducing the breeding of mosquitoes through source reduction (removal and modification of breeding sites) and reducing contact between mosquitoes and people. This can be achieved by reducing the number of natural and artificial water-filled habitats that support mosquito larvae, reducing the adult mosquito populations around at-risk communities and by using barriers such as insect screens, closed doors and windows, long clothing and repellents. Since the Aedes mosquitoes (the primary vector for transmission) are day-biting mosquitoes, it is recommended that those who sleep during the daytime, particularly young children, the sick or elderly, should rest under mosquito nets (bed nets), treated with or without insecticide to provide protection.
 
Source: http://www.who.int/csr/don/10-march-2016-dengue-uruguay/en/
[h=1]Dengue Fever ? Uruguay[/h] Disease Outbreak News
10 March 2016

On 1 March 2016, the National IHR Focal Point of Uruguay provided PAHO/WHO with an update on the country?s ongoing dengue outbreak.
Since the confirmation of the first autochthonous case (see DON published on 25 February), Uruguay has been experiencing a sustained increase in the number of notifications of suspected and confirmed cases (570 and 17, respectively). The majority of cases have occurred in three departments: Montevideo (59%), Canelones (17%) and Salto (4%).
All confirmed cases were positive for dengue virus by reverse transcription polymerase chain reaction (RT-PCR). The serotype circulating is DEN 1.
[h=3]Public health response[/h] Health authorities in Uruguay have implemented measures for strengthening integrated vector control, alongside updating clinical management guidelines and emergency risk communications.
An international team of technical experts has been deployed to Uruguay to support the response operations. The team consists of an epidemiologist, entomologist and a risk communication specialist.
[h=3]WHO risk assessment[/h] The detection of cases of dengue demonstrates that an environment favourable to the proliferation of the Aedes Aegypti mosquitoes is present. Based on experiences from previous similar events, it is expected that additional cases will be reported in Uruguay. This event, however, does not represent a risk for neighbouring countries in the Americas Region since they have already reported dengue circulation. WHO continues to monitor the epidemiological situation and conducts risk assessment based on the latest available information.
[h=3]WHO advice[/h] The proximity of mosquito vector breeding sites to human habitation is a significant risk factor for dengue virus infection. Prevention and control relies on reducing the breeding of mosquitoes through source reduction (removal and modification of breeding sites) and reducing contact between mosquitoes and people. This can be achieved by reducing the number of natural and artificial water-filled habitats that support mosquito larvae, reducing the adult mosquito populations around at-risk communities and by using barriers such as insect screens, closed doors and windows, long clothing and repellents. Since the Aedes mosquitoes (the primary vector for transmission) are day-biting mosquitoes, it is recommended that those who sleep during the daytime, particularly young children, the sick or elderly, should rest under mosquito nets (bed nets), treated with or without insecticide to provide protection.
During outbreaks, space spraying of insecticides may be carried out following the technical orientation provided by WHO to kill flying mosquitoes. Suitable insecticides (recommended by the WHO Pesticide Evaluation Scheme) may also be used as larvicides to treat relatively large water containers, when this is technically indicated. Source reduction with active community support should be encouraged.
Basic precautions for protection from mosquito bites should be taken by people traveling to high risk areas. These include use of repellents, wearing light colored, long sleeved shirts and pants and ensuring rooms are fitted with screens to prevent mosquitoes from entering.
WHO does not recommend any travel or trade restriction to Uruguay based on the current information available.
 
Back
Top Bottom